BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 32920168)

  • 21. Patient-reported Outcomes as Predictors of Change in Disease Activity and Disability in Early Rheumatoid Arthritis: Results from the Yorkshire Early Arthritis Register.
    Twigg S; Hensor EMA; Emery P; Tennant A; Morgan AW;
    J Rheumatol; 2017 Sep; 44(9):1331-1340. PubMed ID: 28668806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient- and clinician-reported outcomes for patients with new presentation of inflammatory arthritis: observations from the National Clinical Audit for Rheumatoid and Early Inflammatory Arthritis.
    Ledingham JM; Snowden N; Rivett A; Galloway J; Ide Z; Firth J; MacPhie E; Kandala N; Dennison EM; Rowe I
    Rheumatology (Oxford); 2017 Feb; 56(2):231-238. PubMed ID: 27694336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ten years of change in clinical disease status and treatment in rheumatoid arthritis: results based on standardized monitoring of patients in an ordinary outpatient clinic in southern Norway.
    Haugeberg G; Hansen IJ; Soldal DM; Sokka T
    Arthritis Res Ther; 2015 Aug; 17(1):219. PubMed ID: 26290061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Routine Assessment of Patient Index Data 3 (RAPID3) alone is insufficient to monitor disease activity in rheumatoid arthritis in clinical practice.
    Boone NW; Sepriano A; van der Kuy PH; Janknegt R; Peeters R; Landewé RBM
    RMD Open; 2019; 5(2):e001050. PubMed ID: 31908842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. American College of Rheumatology/European League Against Rheumatism remission criteria for rheumatoid arthritis maintain reliable performance when evaluated in 44 joints.
    Kaneko Y; Kondo H; Takeuchi T
    J Rheumatol; 2013 Aug; 40(8):1254-8. PubMed ID: 23772077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multi-center, observational study shows high proportion of Australian rheumatoid arthritis patients have inadequate disease control.
    Littlejohn G; Roberts L; Arnold M; Bird P; Burnet S; de Jager J; Griffiths H; Nicholls D; Scott J; Zochling J; Tymms KE
    Int J Rheum Dis; 2013 Oct; 16(5):532-8. PubMed ID: 24164840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics of patients with rheumatoid arthritis in Qatar: a cross-sectional study.
    Lutf A; Poil AR; Hammoudeh M
    Int J Rheum Dis; 2014 Jan; 17(1):63-5. PubMed ID: 24472269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rheumatoid Arthritis Disease Activity Predicting Incident Clinically Apparent Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Prospective Cohort Study.
    Sparks JA; He X; Huang J; Fletcher EA; Zaccardelli A; Friedlander HM; Gill RR; Hatabu H; Nishino M; Murphy DJ; Iannaccone CK; Mahmoud TG; Frits ML; Lu B; Rosas IO; Dellaripa PF; Weinblatt ME; Karlson EW; Shadick NA; Doyle TJ
    Arthritis Rheumatol; 2019 Sep; 71(9):1472-1482. PubMed ID: 30951251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors associated with the intensification of treatment in rheumatoid arthritis in clinical practice.
    Naranjo A; Cáceres L; Hernández-Beriaín JÁ; Francisco F; Ojeda S; Talaverano S; Nóvoa-Medina J; Martín JA; Delgado E; Trujillo E; Álvarez F; Magdalena L; Rodríguez-Lozano C
    Rheumatol Int; 2015 Nov; 35(11):1851-5. PubMed ID: 26238094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The longitudinal effect of biologic use on patient outcomes (disease activity, function, and disease severity) within a rheumatoid arthritis registry.
    Shadick NA; Gerlanc NM; Frits ML; Stolshek BS; Brady BL; Iannaccone C; Collier D; Cui J; Mutebi A; Weinblatt ME
    Clin Rheumatol; 2019 Nov; 38(11):3081-3092. PubMed ID: 31353421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relative importance of doctor-reported outcomes vs patient-reported outcomes in DMARD intensification for rheumatoid arthritis: the DUO study.
    Dougados M; Nataf H; Steinberg G; Rouanet S; Falissard B
    Rheumatology (Oxford); 2013 Feb; 52(2):391-9. PubMed ID: 23104976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sustained clinical remission of rheumatoid arthritis and its predictive factors in an unselected adult Chinese population from 2009 to 2018.
    Xie W; Li J; Zhang X; Sun X; Zhang Z
    Int J Rheum Dis; 2019 Sep; 22(9):1670-1678. PubMed ID: 31297977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Barriers to optimal disease control for rheumatoid arthritis patients with moderate and high disease activity.
    Tymms K; Zochling J; Scott J; Bird P; Burnet S; de Jager J; Griffiths H; Nicholls D; Roberts L; Arnold M; Littlejohn G
    Arthritis Care Res (Hoboken); 2014 Feb; 66(2):190-6. PubMed ID: 23983001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In wealthier countries, patients perceive worse impact of the disease although they have lower objectively assessed disease activity: results from the cross-sectional COMORA study.
    Putrik P; Ramiro S; Hifinger M; Keszei AP; Hmamouchi I; Dougados M; Gossec L; Boonen A
    Ann Rheum Dis; 2016 Apr; 75(4):715-20. PubMed ID: 26314921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient Acceptable Symptom State in Self-Report Questionnaires and Composite Clinical Disease Index for Assessing Rheumatoid Arthritis Activity: Identification of Cut-Off Points for Routine Care.
    Salaffi F; Carotti M; Gutierrez M; Di Carlo M; De Angelis R
    Biomed Res Int; 2015; 2015():930756. PubMed ID: 26167506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient-reported outcomes in Asia: evaluation of the properties of the Rheumatoid Arthritis Impact of Disease (RAID) score in multiethnic Asian patients with rheumatoid arthritis.
    Cheung PP; Lahiri M; March L; Gossec L
    Clin Rheumatol; 2017 May; 36(5):1149-1154. PubMed ID: 28039541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overweight decreases the chance of achieving good response and low disease activity in early rheumatoid arthritis.
    Sandberg ME; Bengtsson C; Källberg H; Wesley A; Klareskog L; Alfredsson L; Saevarsdottir S
    Ann Rheum Dis; 2014 Nov; 73(11):2029-33. PubMed ID: 24818635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RAPID3 (Routine Assessment of Patient Index Data 3), a rheumatoid arthritis index without formal joint counts for routine care: proposed severity categories compared to disease activity score and clinical disease activity index categories.
    Pincus T; Swearingen CJ; Bergman M; Yazici Y
    J Rheumatol; 2008 Nov; 35(11):2136-47. PubMed ID: 18793006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting ultrasound remission in early rheumatoid arthritis: the results of the TaSER study, a randomised clinical trial.
    Dale J; Stirling A; Zhang R; Purves D; Foley J; Sambrook M; Conaghan PG; van der Heijde D; McConnachie A; McInnes IB; Porter D
    Ann Rheum Dis; 2016 Jun; 75(6):1043-50. PubMed ID: 27026689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of the different "patient global assessment" formulations on disease activity score by different indices in rheumatoid arthritis.
    Ferreira RJO; Eugénio G; Ndosi M; Silva C; Medeiros C; Duarte C; da Silva JAP
    Clin Rheumatol; 2018 Jul; 37(7):1963-1969. PubMed ID: 29525844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.